Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2015 Publisher: Biofactor GmbH, Rudolf-Huch-Str. 14, D-38667 Bad Harzburg, Germany, Fax: +49 5322 960516, Email: info@biofactor.de
Biofactor Streptokinase 1 500 000.
| Pharmaceutical Form |
|---|
|
Powder for solution for infusion. White to slightly yellow powder. |
Biofactor Streptokinase 1 500 000 is presented as a powder for solution in vials containing 1.5 million International Units (IU) of purified streptokinase as the active ingredient. For a full list of excipients, see section 6.1.
Highly purified streptokinase is extracted from the culture filtrate of certain strains of the streptococcus group C. It is presented as a white to slightly yellow powder and contains stabilisers.
| Active Ingredient | Description | |
|---|---|---|
| Streptokinase |
Biofactor streptokinase is a highly purified streptokinase derived from β haemolytic streptococci of Lancefield group C. The activation of the endogenous fibrinolytic system is initiated by the formation of a streptokinase-plasminogen complex. This complex possesses activator properties and converts plasminogen into the proteolytic and fibrinolytic active plasmin. |
| List of Excipients |
|---|
|
Human albumin |
Biofactor Streptokinase 1 500 000 is supplied in glass vials with rubber closures and aluminium seal with plastic flip-top caps.
Biofactor Streptokinase 1 500 000 is available in packages containing one vial.
Biofactor GmbH, Rudolf-Huch-Str. 14, D-38667 Bad Harzburg, Germany, Fax: +49 5322 960516, Email: info@biofactor.de
PL 29723/0004
26 June 1998/15 May 2009
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
